210 related articles for article (PubMed ID: 3120068)
41. Clinical outcome of pathologic Stage IIA endometrial adenocarcinoma after intravaginal brachytherapy alone.
Siddiqui F; Ibrahim DR; Aref I; Lu M; Kim WS; Schultz D; Elshaikh MA
Brachytherapy; 2009; 8(4):396-400. PubMed ID: 19733127
[TBL] [Abstract][Full Text] [Related]
42. [Morphologic prognostic criteria in endometrial cancer with special reference to nuclear grading].
Schneider ML
Geburtshilfe Frauenheilkd; 1986 May; 46(5):267-77. PubMed ID: 3721157
[TBL] [Abstract][Full Text] [Related]
43. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
Papanikolaou A; Kalogiannidis I; Goutzioulis M; Misailidou D; Makedos A; Vergote I; Makedos G
Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
[TBL] [Abstract][Full Text] [Related]
44. [Recurrence of endometrial cancer and its pathological factors].
Kondo Y; Gorai I; Yanagibashi T; Yanagisawa T; Hirahara F; Ohtsuka T; Kimura A; Uemura T; Minaguchi H; Kikyo S
Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1105-9. PubMed ID: 2398296
[TBL] [Abstract][Full Text] [Related]
45. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
[TBL] [Abstract][Full Text] [Related]
46. Adjunctive radiation therapy in the management of stage I cancer of the endometrium.
Surwit EA; Joelsson I; Einhorn N
Obstet Gynecol; 1981 Nov; 58(5):590-5. PubMed ID: 7301235
[TBL] [Abstract][Full Text] [Related]
47. Combined assessment of vascular and myometrial invasion as a model to predict prognosis in stage I endometrioid adenocarcinoma of the uterine corpus.
Ambros RA; Kurman RJ
Cancer; 1992 Mar; 69(6):1424-31. PubMed ID: 1371712
[TBL] [Abstract][Full Text] [Related]
48. A prospective trial of postoperative vaginal radium/cesium for grade 1-2 less than 50% myometrial invasion and pelvic radiation therapy for grade 3 or deep myometrial invasion in surgical stage I endometrial adenocarcinoma.
Piver MS; Hempling RE
Cancer; 1990 Sep; 66(6):1133-8. PubMed ID: 2400965
[TBL] [Abstract][Full Text] [Related]
49. Endometrial adenocarcinoma histologic subtypes: clinical and pathologic profile.
Fanning J; Evans MC; Peters AJ; Samuel M; Harmon ER; Bates JS
Gynecol Oncol; 1989 Mar; 32(3):288-91. PubMed ID: 2920949
[TBL] [Abstract][Full Text] [Related]
50. Combined surgery and radiation in endometrial carcinoma: an analysis of prognostic factors.
Nori D; Hilaris BS; Tome M; Lewis JL; Birnbaum S; Fuks Z
Int J Radiat Oncol Biol Phys; 1987 Apr; 13(4):489-97. PubMed ID: 3104248
[TBL] [Abstract][Full Text] [Related]
51. Adenocarcinoma of the endometrium. Analysis of 256 cases with disease limited to the uterine corpus: treatment comparisons.
Eifel PJ; Ross J; Hendrickson M; Cox RS; Kempson R; Martinez A
Cancer; 1983 Sep; 52(6):1026-31. PubMed ID: 6883271
[TBL] [Abstract][Full Text] [Related]
52. Stage II carcinoma of the endometrium. An analysis of treatment.
Surwit EA; Fowler WC; Rogoff EE
Obstet Gynecol; 1978 Jul; 52(1):97-9. PubMed ID: 567310
[TBL] [Abstract][Full Text] [Related]
53. [Postoperative radiotherapy in endometrial adenocarcinoma].
Giordana C; Malinverni G; Rosmino C; Del Tetto F
Minerva Ginecol; 1990 Oct; 42(10):405-9. PubMed ID: 2290598
[TBL] [Abstract][Full Text] [Related]
54. Adjuvant radiation therapy in endometrial carcinoma.
Garrett P; Pugh N; Ross D; Rate W
Indiana Med; 1990 Aug; 83(8):560-2. PubMed ID: 2212585
[TBL] [Abstract][Full Text] [Related]
55. [Clinical studies of 145 cases of endometrial carcinoma--analysis of prognostic factors, especially pathological types].
Fukuma K; Tohya T; Souda Y; Fuzisaki S; Maeyama M; Mimori H
Nihon Sanka Fujinka Gakkai Zasshi; 1986 Sep; 38(9):1508-14. PubMed ID: 3772201
[TBL] [Abstract][Full Text] [Related]
56. Endometrial adenocarcinoma, adjuvant radiotherapy tailored to prognostic factors.
Meerwaldt JH; Hoekstra CJ; van Putten WL; Tjokrowardojo AJ; Koper PC
Int J Radiat Oncol Biol Phys; 1990 Feb; 18(2):299-304. PubMed ID: 2303362
[TBL] [Abstract][Full Text] [Related]
57. Residual carcinoma in the surgical specimen of patients with endometrial adenocarcinoma undergoing preoperative radiation therapy. A study of 80 patients and a literature review.
Nahhas WA; Zaino R; Mortel R
Gynecol Oncol; 1984 Jun; 18(2):165-76. PubMed ID: 6735261
[TBL] [Abstract][Full Text] [Related]
58. Assessment of depth of myometrial invasion in endometrial adenocarcinoma.
Goff BA; Rice LW
Gynecol Oncol; 1990 Jul; 38(1):46-8. PubMed ID: 2354826
[TBL] [Abstract][Full Text] [Related]
59. The role of radiation therapy in the treatment of adenocarcinoma of the corpus uteri stage I. A ten year experience (1970-1979).
Calitchi E; Lobo PA; Martin M; Mazeron JJ; Le Bourgeois JP; Pierquin B
Acta Radiol Oncol; 1984; 23(6):461-4. PubMed ID: 6099040
[TBL] [Abstract][Full Text] [Related]
60. [Endometrial carcinoma--stage I. Evaluation of risk and prognostic factors in an analysis of 120 cases].
Romano FM; Bruno G; Manicastri AM
Minerva Ginecol; 1991 Mar; 43(3):97-104. PubMed ID: 2057108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
